🇮🇹 Bevacizumab in Italy

AIFA authorised Bevacizumab on 1 December 2005

Marketing authorisation

AIFA — authorised 1 December 2005

  • Marketing authorisation holder: Roche Registration Limited
  • Status: approved

Bevacizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Italy

Frequently asked questions

Is Bevacizumab approved in Italy?

Yes. AIFA authorised it on 1 December 2005.

Who is the marketing authorisation holder for Bevacizumab in Italy?

Roche Registration Limited holds the Italian marketing authorisation.